| Therapeutic property | Disease or Causative microorganism | Type of evidence | References |
| Antimicotic | Canine otitis | Clinical experience | [10] [11] |
| Malassezia pachydermatis | |||
| Candida spp. | |||
| Dermatophytosis | Clinical experience | [12] | |
| Microsporum canis | |||
| Microsporum gypseum | |||
| Antineoplasic | Transmissible venereal tumor | Experimental (in vitro) | [3] |
| Osteosarcoma | [4] | ||
| Cushing’s syndrome | Clinical experience | [5] | |
| Bactericide | Staphylococcus aureus | Experimental (in vitro) | |
| Pseudomonas ssp. | [6] -[8] | ||
| Proteus ssp. | |||
| Escherichia coli | |||
| Immunoestimulant | Canine distemper | Experimental (in vitro, in vivo in mice) | [16] |
| Canine parvovirus | [15] | ||
| Oftalmic | Blefaritis | Clinical experience | |
| Conjuntivitis | [20] [21] | ||
| Queratoconjuntivitis | |||
| Glaucoma | |||
| Paradontal | Gingivitis | Clinical experience | [17] -[19] |
| Paradontitis | |||
| Metabolic | Liver diseases | Clinical experience | [22] |
| Antiparasitic | Giardiais | Experimental (in vitro in rats) | [13] |
| Trypanosomiasis | Experimental (in vitro in mice) | [14] |